Study of effect of Patolmooladi kashay orally and external application of aaragwadhadi lepa in skin disease.
- Conditions
- Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
- Registration Number
- CTRI/2020/03/024370
- Lead Sponsor
- Dr Prajakta Prabhakar Kulkarni
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients with the symptoms of Dadru-
itching
change in colour
erythmatous papulovesicular lesion
Subjects who are willing to involve in the study and give informed consent in written
subjects having positive Microscopic examination of skin scrapping in KOH solution for fungal study
Any underlying uncontrolled medical illness including diabetes mellitus
hypertension
liver disorder
history of chronic alcoholism
hepatitis
severe cardiovascular and pulmonary disorder (where steroid treatment is required)
cerebral neurological disease
psychiatric diseases
Subjects currently recieving drugs like B- blockers, antimalarials and NSAIDs or
using corticosteroids and anti-inflammatory medicines until 15 days before inclusion
into the study
Subjects with history of cancer including skin cancer
Skin disorders other than Dadru will be excluded
Pregnant female
Patients having diarrhoea
bleeding piles
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method